BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18310272)

  • 21. Methylated genes as new cancer biomarkers.
    Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
    Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation.
    Tang H; Goldberg E
    J Androl; 2009; 30(2):157-67. PubMed ID: 18930904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
    Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
    Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Association of mating type switching/sucrose non-fermenting complex with prostate cancer].
    Yang J; Liu JH; Li BY
    Zhonghua Nan Ke Xue; 2008 Oct; 14(10):935-8. PubMed ID: 19157109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switch to full-length of XAF1 mRNA expression in prostate cancer cells by the DNA methylation inhibitor.
    Fang X; Liu Z; Fan Y; Zheng C; Nilson S; Egevad L; Ekman P; Xu D
    Int J Cancer; 2006 May; 118(10):2485-9. PubMed ID: 16353137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism.
    Paone A; Starace D; Galli R; Padula F; De Cesaris P; Filippini A; Ziparo E; Riccioli A
    Carcinogenesis; 2008 Jul; 29(7):1334-42. PubMed ID: 18566014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone.
    Saha B; Kaur P; Tsao-Wei D; Naritoku WY; Groshen S; Datar RH; Jones LW; Imam SA
    Prostate; 2008 Nov; 68(15):1681-8. PubMed ID: 18712716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
    Sørensen KD; Wild PJ; Mortezavi A; Adolf K; Tørring N; Heebøll S; Ulhøi BP; Ottosen P; Sulser T; Hermanns T; Moch H; Borre M; Ørntoft TF; Dyrskjøt L
    Clin Cancer Res; 2009 Feb; 15(4):1400-10. PubMed ID: 19228741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.
    Li T; Li D; Sha J; Sun P; Huang Y
    Biochem Biophys Res Commun; 2009 Jun; 383(3):280-5. PubMed ID: 19302977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy.
    Rabiau N; Thiam MO; Satih S; Guy L; Kemeny JL; Boiteux JP; Fontana L; Bignon YJ; Bernard-Gallon D
    In Vivo; 2009; 23(3):387-91. PubMed ID: 19454503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purine-rich element binding protein (PUR) alpha induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells.
    Inoue T; Maeno A; Talbot C; Zeng Y; Yeater DB; Leman ES; Kulkarni P; Ogawa O; Getzenberg RH
    Prostate; 2009 Jun; 69(8):861-73. PubMed ID: 19267365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoic acid receptor beta2 hypermethylation: implications for prostate cancer detection, prevention, and therapy.
    Lotan R; Lotan Y
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3935-6. PubMed ID: 15217922
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA methylation of GSTP1 as biomarker in diagnosis of prostate cancer.
    Hopkins TG; Burns PA; Routledge MN
    Urology; 2007 Jan; 69(1):11-6. PubMed ID: 17270599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.